Serum copper in ovarian carcinoma.
The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.
Jacobs
A J
AJ
Department of Obstetrics and Gynecology, St. Louis University School of Medicine, MO 63104.
Sommers
G M
GM
Axelrod
J H
JH
Galakatos
A E
AE
Kao
M S
MS
Camel
H M
HM
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D002277:Carcinoma / Q000097:blood* / Q000276:immunology / Q000473:pathology; D003300:Copper / Q000097:blood*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood* / Q000276:immunology / Q000473:pathology; D011379:Prognosis
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D003300:Copper